Related Experiment Videos
Summary
Sepsis-associated jaundice involves intrahepatic cholestasis. This study found endotoxin reduces bile flow, but interleukin-1, interleukin-2, and interferon gamma do not mediate this endotoxin-induced cholestasis in rats.
Area of Science:
- Hepatology and Immunology
- Gastroenterology
- Sepsis Pathophysiology
Background:
- Sepsis can cause jaundice, characterized by intrahepatic cholestasis and minimal hepatocyte necrosis.
- The exact cause of sepsis-induced cholestasis remains unknown.
- Interleukin-1 (IL-1) is a major endogenous pyrogen implicated in systemic inflammatory responses.
Purpose of the Study:
- To investigate if intrahepatic cholestasis during sepsis is a systemic effect of interleukin-1.
- To examine the impact of endotoxin, IL-2, and interferon gamma on biliary secretion and transport.
Main Methods:
- Utilized a bile fistula rat model to study biliary secretion.
- Administered endotoxin, IL-1 (chronic), IL-2, and recombinant rat interferon gamma (rIFNγ).
- Measured basal bile flow, peak bile flow, and sodium taurocholate output at specific intervals (1h or 3h for rIFNγ).
Main Results:
- Endotoxin significantly decreased basal and sodium taurocholate-stimulated bile flow and secretion.
- Acute administration of IL-2 and rIFNγ did not affect bile flow or secretion.
- Chronic administration of IL-1 also showed no effect on the measured biliary parameters.
Conclusions:
- Endotoxin administration induces intrahepatic cholestasis in rats.
- The cholestasis caused by endotoxin is not mediated by IL-1, IL-2, or rIFNγ.
- Further research is needed to elucidate the specific mechanisms of endotoxin-induced cholestasis.